PROCEPT BioRobotics (PRCT) Payables (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Payables for 7 consecutive years, with $15.1 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables rose 27.89% year-over-year to $15.1 million in Q2 2026; TTM through Jun 2026 was $15.1 million, a 27.89% increase from a year earlier, with the FY2025 full-year figure at $17.3 million, up 43.66% from the prior year.
• Payables was $15.1 million for Q2 2026 at PROCEPT BioRobotics, down from $18.9 million in the prior quarter.
• Over five years, Payables peaked at $18.9 million in Q1 2026 and troughed at $2.6 million in Q1 2022.
• A 5-year average of $11.9 million and a median of $11.9 million in 2024 frame the typical range for Payables.
• Across the five-year window, Payables surged 362.84% in 2022 and plunged 34.94% in 2025, its largest moves.
• Over 5 years, Payables stood at $9.4 million in 2022, then surged by 63.83% to $15.4 million in 2023, then declined by 21.79% to $12.0 million in 2024, then soared by 43.66% to $17.3 million in 2025, then declined by 12.82% to $15.1 million in 2026.
• The last three Payables figures came in at $15.1 million (Q2 2026), $18.9 million (Q1 2026), and $17.3 million (Q4 2025), per Business Quant data.